Trial | NCT00032942  Report issue

Title

Lofexidine for Opiate Withdrawal - 1
A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    lofexidine ...

  • Study Participants

    66
The purpose of this study is to evaluate lofexidine for opiate withdrawal.
An 11 day inpatient placebo-controlled, double-blind study of 96 opiate dependent, treatment seeking individuals randomized to 2 medication groups: lofexidine and placebo to be conducted in inpatient units at 3 treatment sites.
Study Started
Apr 30
2001
Primary Completion
Oct 31
2004
Last Update
Jan 12
2017
Estimate

Drug Lofexidine

Criteria 

Inclusion Criteria:

Male or female as least 18 yrs of age & above with a current dependence on heroin, morphine or hydromorphone according to DSM4 criteria; subject ; voluntarily given consent and signed informed consent; females using appropriate birth control method.

Exclusion Criteria:

Additional criteria available during screening at the site
No Results Posted